{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:19:44Z","timestamp":1761844784588},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00535-017-1386-2","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T07:46:15Z","timestamp":1503906375000},"page":"740-751","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B"],"prefix":"10.1007","volume":"53","author":[{"given":"Kazunori","family":"Kawaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Shimakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Komura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Unoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"key":"1386_CR1","first-page":"1722","volume":"61","author":"C Fu","year":"2014","unstructured":"Fu C, Liu N, Deng Q, et al. Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials. Hepatogastroenterology. 2014;61:1722\u20139.","journal-title":"Hepatogastroenterology"},{"key":"1386_CR2","first-page":"710","volume":"62","author":"W Guo","year":"2015","unstructured":"Guo W, He X, Li Z, Li Y. Combination of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) vs. surgical resection (SR) on survival outcome of early hepatocellular carcinoma: a meta-analysis. Hepatogastroenterology. 2015;62:710\u20134.","journal-title":"Hepatogastroenterology"},{"key":"1386_CR3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jgh.13229","volume":"31","author":"N Hiramatsu","year":"2016","unstructured":"Hiramatsu N, Yamada R, Takehara T. The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients. J Gastroenterol Hepatol. 2016;31:546\u201352.","journal-title":"J Gastroenterol Hepatol"},{"key":"1386_CR4","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.3748\/wjg.v19.i47.8861","volume":"19","author":"T Ishikawa","year":"2013","unstructured":"Ishikawa T. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2013;19:8861\u20136.","journal-title":"World J Gastroenterol"},{"key":"1386_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.canep.2011.11.006","volume":"36","author":"Q Wang","year":"2012","unstructured":"Wang Q, Zhang T, Ye L, et al. Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China. Cancer Epidemiol. 2012;36:369\u201374.","journal-title":"Cancer Epidemiol"},{"key":"1386_CR6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.27654","volume":"61","author":"B Suh","year":"2015","unstructured":"Suh B, Park S, Shin DW, et al. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology. 2015;61:1261\u20138.","journal-title":"Hepatology"},{"key":"1386_CR7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.","journal-title":"Sci Rep"},{"key":"1386_CR8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","volume":"60","author":"K Yamasaki","year":"2014","unstructured":"Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563\u201370.","journal-title":"Hepatology"},{"key":"1386_CR9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","volume":"110","author":"T Umemura","year":"2015","unstructured":"Umemura T, Joshita S, Sekiguchi T, et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 2015;110:857\u201364.","journal-title":"Am J Gastroenterol"},{"key":"1386_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","volume":"50","author":"T Toshima","year":"2015","unstructured":"Toshima T, Shirabe K, Ikegami T, et al. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol. 2015;50:76\u201384.","journal-title":"J Gastroenterol"},{"key":"1386_CR11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/hepr.12596","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. Hepatol Res. 2016;46:613\u201321.","journal-title":"Hepatol Res"},{"key":"1386_CR12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/hepr.12662","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level in non-alcoholic steatohepatitis. Hepatol Res. 2016;46:1194\u2013202.","journal-title":"Hepatol Res"},{"key":"1386_CR13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","volume":"50","author":"M Abe","year":"2015","unstructured":"Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol. 2015;50:776\u201384.","journal-title":"J Gastroenterol"},{"key":"1386_CR14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00535-015-1063-2","volume":"50","author":"M Fujiyoshi","year":"2015","unstructured":"Fujiyoshi M, Kuno A, Gotoh M, et al. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol. 2015;50:1134\u201344.","journal-title":"J Gastroenterol"},{"key":"1386_CR15","doi-asserted-by":"crossref","first-page":"e0129053","DOI":"10.1371\/journal.pone.0129053","volume":"10","author":"R Sasaki","year":"2015","unstructured":"Sasaki R, Yamasaki K, Abiru S, et al. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response. PLoS One. 2015;10:e0129053.","journal-title":"PLoS One"},{"key":"1386_CR16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/hepr.12655","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical implication of serum WFA+-M2BP level on hepatitis B e antigen loss or seroconversion in hepatitis B e antigen-positive patients. Hepatol Res. 2016;46:1065\u201373.","journal-title":"Hepatol Res"},{"key":"1386_CR17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/liv.13024","volume":"36","author":"D Zhou","year":"2016","unstructured":"Zhou D, Wang Y, Zhang W, et al. WFA(+) -M2BP: a novel biomarker with diagnostic and therapeutic implications in liver diseases. Liver Int. 2016;36:612.","journal-title":"Liver Int"},{"key":"1386_CR18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/hepr.12703","volume":"47","author":"A Ishii","year":"2017","unstructured":"Ishii A, Nishikawa H, Enomoto H, et al. Clinical implication of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment na\u00efve chronic hepatitis B. Hepatol Res. 2017;47:204\u201315.","journal-title":"Hepatol Res."},{"key":"1386_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/liv.13188","volume":"37","author":"X Zou","year":"2017","unstructured":"Zou X, Zhu MY, Yu DM, et al. Serum WFA(+) -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int. 2017;37:35\u201344.","journal-title":"Liver Int"},{"key":"1386_CR20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/liv.13341","volume":"37","author":"SU Kim","year":"2017","unstructured":"Kim SU, Heo JY, Kim BK, et al. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development. Liver Int. 2017;37:879\u201387.","journal-title":"Liver Int."},{"key":"1386_CR21","doi-asserted-by":"crossref","first-page":"e3328","DOI":"10.1097\/MD.0000000000003328","volume":"95","author":"JY Heo","year":"2016","unstructured":"Heo JY, Kim SU, Kim BK, et al. Use of Wisteria floribunda agglutinin-positive human Mac-2 binding protein in assessing risk of hepatocellular carcinoma due to hepatitis B virus. Medicine (Baltimore). 2016;95:e3328.","journal-title":"Medicine (Baltimore)"},{"key":"1386_CR22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JCM.40.2.439-445.2002","volume":"40","author":"T Kimura","year":"2002","unstructured":"Kimura T, Rokuhara A, Sakamoto Y, et al. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol. 2002;40:439\u201345.","journal-title":"J Clin Microbiol"},{"key":"1386_CR23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2893.2003.00437.x","volume":"10","author":"A Rokuhara","year":"2003","unstructured":"Rokuhara A, Tanaka E, Matsumoto A, et al. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. J Viral Hepat. 2003;10:324\u201330.","journal-title":"J Viral Hepat"},{"key":"1386_CR24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.hepres.2006.08.005","volume":"36","author":"N Shinkai","year":"2006","unstructured":"Shinkai N, Tanaka Y, Orito E, et al. Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection. Hepatol Res. 2006;36:272\u20136.","journal-title":"Hepatol Res"},{"key":"1386_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1872-034X.2007.00094.x","volume":"37","author":"A Matsumoto","year":"2007","unstructured":"Matsumoto A, Tanaka E, Minami M, et al. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy. Hepatol Res. 2007;37:661\u20136.","journal-title":"Hepatol Res"},{"key":"1386_CR26","doi-asserted-by":"crossref","first-page":"21713","DOI":"10.1074\/jbc.M501564200","volume":"280","author":"T Kimura","year":"2005","unstructured":"Kimura T, Ohno N, Terada N, et al. Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain. J Biol Chem. 2005;280:21713\u20139.","journal-title":"J Biol Chem"},{"key":"1386_CR27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/infdis\/jiv572","volume":"213","author":"M Honda","year":"2016","unstructured":"Honda M, Shirasaki T, Terashima T, et al. Hepatitis B virus (HBV) core-related antigen during nucleos(t)ide analog therapy is related to intra-hepatic HBV replication and development of hepatocellular carcinoma. J Infect Dis. 2016;213:1096\u2013106.","journal-title":"J Infect Dis"},{"key":"1386_CR28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32\u20136.","journal-title":"Hepatology"},{"key":"1386_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","volume":"8","author":"L Men\u00e9ndez-Arias","year":"2014","unstructured":"Men\u00e9ndez-Arias L, \u00c1lvarez M, Pacheco B. Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance. Curr Opin Virol. 2014;8:1\u20139.","journal-title":"Curr Opin Virol"},{"key":"1386_CR30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.clinre.2014.12.003","volume":"39","author":"BW Xia","year":"2015","unstructured":"Xia BW, Zhang YC, Wang J, et al. Efficacy of antiviral therapy with nucleotide\/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39:458\u201368.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"1386_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.12394","volume":"34","author":"M Triolo","year":"2014","unstructured":"Triolo M, Della Corte C, Colombo M. Impact of HBV therapy on the incidence of hepatocellular carcinoma. Liver Int. 2014;34(1):139\u201345.","journal-title":"Liver Int"},{"key":"1386_CR32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/prca.201300010","volume":"7","author":"A Kuno","year":"2013","unstructured":"Kuno A, Sato T, Shimazaki H, et al. Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin Appl. 2013;7:642\u20137.","journal-title":"Proteomics Clin Appl"},{"key":"1386_CR33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23654","volume":"52","author":"A Matsuda","year":"2010","unstructured":"Matsuda A, Kuno A, Kawamoto T, et al. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology. 2010;52:174\u201382.","journal-title":"Hepatology"},{"key":"1386_CR34","first-page":"182","volume":"11","author":"XD Zhang","year":"2014","unstructured":"Zhang XD, Wang Y, Ye LH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med. 2014;11:182\u201390.","journal-title":"Cancer Biol Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1386-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T11:18:38Z","timestamp":1602847118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1386-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1386-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,28]]}}}